|
|
Line 3: |
Line 3: |
| <StructureSection load='5tbd' size='340' side='right'caption='[[5tbd]], [[Resolution|resolution]] 2.20Å' scene=''> | | <StructureSection load='5tbd' size='340' side='right'caption='[[5tbd]], [[Resolution|resolution]] 2.20Å' scene=''> |
| == Structural highlights == | | == Structural highlights == |
- | <table><tr><td colspan='2'>[[5tbd]] is a 12 chain structure with sequence from [http://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5TBD OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5TBD FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5tbd]] is a 12 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus] and [https://en.wikipedia.org/wiki/Plasmodium_falciparum_3D7 Plasmodium falciparum 3D7]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5TBD OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5TBD FirstGlance]. <br> |
- | </td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.2Å</td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5tbd FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5tbd OCA], [http://pdbe.org/5tbd PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5tbd RCSB], [http://www.ebi.ac.uk/pdbsum/5tbd PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5tbd ProSAT]</span></td></tr> | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5tbd FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5tbd OCA], [https://pdbe.org/5tbd PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5tbd RCSB], [https://www.ebi.ac.uk/pdbsum/5tbd PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5tbd ProSAT]</span></td></tr> |
| </table> | | </table> |
| + | == Function == |
| + | [https://www.uniprot.org/uniprot/MSA2_PLAF7 MSA2_PLAF7] May play a role in the merozoite attachment to the erythrocyte. |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
Line 21: |
Line 24: |
| </StructureSection> | | </StructureSection> |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: Lk3 transgenic mice]] | + | [[Category: Mus musculus]] |
- | [[Category: Anders, R F]] | + | [[Category: Plasmodium falciparum 3D7]] |
- | [[Category: Atreya, H S]] | + | [[Category: Anders RF]] |
- | [[Category: Bankala, K]] | + | [[Category: Atreya HS]] |
- | [[Category: Christ, D]] | + | [[Category: Bankala K]] |
- | [[Category: Dingjan, T]] | + | [[Category: Christ D]] |
- | [[Category: Drinkwater, N]] | + | [[Category: Dingjan T]] |
- | [[Category: Jaipuria, G]] | + | [[Category: Drinkwater N]] |
- | [[Category: MacRaild, C A]] | + | [[Category: Jaipuria G]] |
- | [[Category: McGowan, S]] | + | [[Category: MacRaild CA]] |
- | [[Category: Morales, R A.V]] | + | [[Category: McGowan S]] |
- | [[Category: Norton, R S]] | + | [[Category: Morales RAV]] |
- | [[Category: Seow, J]] | + | [[Category: Norton RS]] |
- | [[Category: Wilde, K]] | + | [[Category: Seow J]] |
- | [[Category: C-terminal msp2]]
| + | [[Category: Wilde K]] |
- | [[Category: Immune system]]
| + | |
- | [[Category: Immunoglobulin fold]]
| + | |
- | [[Category: Unstructured antigen]]
| + | |
| Structural highlights
Function
MSA2_PLAF7 May play a role in the merozoite attachment to the erythrocyte.
Publication Abstract from PubMed
Merozoite surface protein 2 (MSP2) is an intrinsically disordered antigen that is abundant on the surface of the malaria parasite Plasmodium falciparum. The two allelic families of MSP2, 3D7 and FC27, differ in their central variable regions, which are flanked by highly conserved C-terminal and N-terminal regions. In a vaccine trial, full-length 3D7 MSP2 induced a strain-specific protective immune response despite the detectable presence of conserved region antibodies. This work focuses on the conserved C-terminal region of MSP2, which includes the only disulphide bond in the protein and encompasses key epitopes recognised by the mouse monoclonal antibodies 4D11 and 9H4. Although the 4D11 and 9H4 epitopes are overlapping, immunofluorescence assays have shown that the mouse monoclonal antibody 4D11 binds to MSP2 on the merozoite surface with a much stronger signal than 9H4. Understanding the structural basis for this antigenic difference between these antibodies will help direct the design of a broad-spectrum and MSP2-based malaria vaccine. 4D11 and 9H4 were reengineered into antibody fragments [variable region fragment (Fv) and single-chain Fv (scFv)] and were validated as suitable models for their full-sized IgG counterparts by surface plasmon resonance and isothermal titration calorimetry. An alanine scan of the 13-residue epitope 3D7-MSP2207-222 identified the minimal binding epitope of 4D11 and the key residues involved in binding. A 2.2-A crystal structure of 4D11 Fv bound to the eight-residue epitope NKENCGAA provided valuable insight into the possible conformation of the C-terminal region of MSP2 on the parasite. This work underpins continued efforts to optimise recombinant MSP2 constructs for evaluation as potential vaccine candidates.
Structure and Characterisation of a Key Epitope in the Conserved C-Terminal Domain of the Malaria Vaccine Candidate MSP2.,Seow J, Morales RA, MacRaild CA, Krishnarjuna B, McGowan S, Dingjan T, Jaipuria G, Rouet R, Wilde KL, Atreya HS, Richards JS, Anders RF, Christ D, Drinkwater N, Norton RS J Mol Biol. 2017 Feb 8. pii: S0022-2836(17)30067-0. doi:, 10.1016/j.jmb.2017.02.003. PMID:28189425[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Seow J, Morales RA, MacRaild CA, Krishnarjuna B, McGowan S, Dingjan T, Jaipuria G, Rouet R, Wilde KL, Atreya HS, Richards JS, Anders RF, Christ D, Drinkwater N, Norton RS. Structure and Characterisation of a Key Epitope in the Conserved C-Terminal Domain of the Malaria Vaccine Candidate MSP2. J Mol Biol. 2017 Feb 8. pii: S0022-2836(17)30067-0. doi:, 10.1016/j.jmb.2017.02.003. PMID:28189425 doi:http://dx.doi.org/10.1016/j.jmb.2017.02.003
|